The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study
Open Access
Abstract
Objective To investigate the population impact on the incidence of suicide and non-fatal self harm of regulatory action in 2003 to restrict the use of selective serotonin reuptake inhibitors (SSRIs) in under 18s. Design Ecological time series study. Setting United Kingdom. Populations Young people in the UK aged 12-19 years (prescribing trends), in England and Wales aged 12-17 years (mortality), and in England aged 12-17 years (hospital admissions). Main outcome measures Deaths from suicide and hospital admissions for self harm. Results Antidepressant prescribing doubled between 1999 and 2003 but fell to the 1999 level between 2004 and 2005. These large changes in prescribing did not seem to be associated with temporal trends in suicide or self harm. In the years 1993 to 2005 the annual percentage reduction for suicide among 12-17 year olds was −3.9% (95% confidence interval −6.2% to −1.5%) in males and −3.0% (−6.6% to 0.6%) in females, with no indication of a substantial change in this rate of decrease during that period. Similarly, hospital admission rates for self harm in the years 1999 to 2005 indicated an annual percentage increase for males of 1.1% (−0.5% to 2.7%) and for females of 5.7% (3.6% to 7.8%), again with no statistical evidence of a change in rate after the regulatory action. Conclusions The noticeable reduction in prescribing of antidepressants since regulatory action in 2003 to restrict the use of SSRIs in under 18s does not seem to have been associated with changes in suicidal behaviour in young people. Specifically, these data for England do not indicate that reductions in antidepressant use have led to an increase in suicidal behaviour.Keywords
This publication has 13 references indexed in Scilit:
- The Black Box Warning: Decreased Prescriptions and Increased Youth Suicide?American Journal of Psychiatry, 2007
- SSRI Prescriptions and the Rate of SuicideAmerican Journal of Psychiatry, 2007
- Early Evidence on the Effects of Regulators’ Suicidality Warnings on SSRI Prescriptions and Suicide in Children and AdolescentsAmerican Journal of Psychiatry, 2007
- Decline in Treatment of Pediatric Depression After FDA Advisory on Risk of Suicidality With SSRIsAmerican Journal of Psychiatry, 2007
- Impact of the FDA Black Box Warning on Physician Antidepressant Prescribing and Practice Patterns: Opening Pandora's Suicide BoxMayo Clinic Proceedings, 2007
- Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001–2004British Journal of Clinical Pharmacology, 2005
- Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UKDrug Safety, 2005
- Antidepressants and suicide: what is the balance of benefit and harmBMJ, 2004
- Relationship Between Antidepressant Medication Treatment and Suicide in AdolescentsArchives of General Psychiatry, 2003
- Why are suicide rates rising in young men but falling in the elderly?—a time-series analysis of trends in England and Wales 1950–1998Social Science & Medicine, 2003